Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical presentation of MEN 2A in index vs. non-index patients.

Endocrine - 1 Nov 2023

Machens Andreas, Lorenz Kerstin, Weber Frank, Brandenburg Tim, Führer-Sakel Dagmar, Dralle Henning

Abstract excerpt

PURPOSE: Differences in syndromic manifestations of multiple endocrine neoplasia 2 A (MEN2A) between index and non-index patients are ill-defined. METHODS: Cross-sectional analysis of 602 REarranged during Transfection (RET) carriers (156 index and 446 non-index patients) who underwent thyroidectomy, adrenalectomy, and/or parathyroidectomy between 1985 and 2022, stratified by mutational risk. RESULTS: Index...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Thyroidectomy
Share to Adrenal Gland Neoplasms
Share to Cross-Sectional Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multiple Endocrine Neoplasia Type 2a

Share to Mutation

Share to Pheochromocytoma

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 37477781
DOI: 10.1007/s12020-023-03459-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical presentation of MEN 2A in index vs. non-index patients.PMID 37477781Read ↗

The Changing Face of Multiple Endocrine Neoplasia 2A: From Symptom-Based to Preventative MedicineSemantic proximity Read ↗

100-Year evolution of precision medicine and surgery for multiple endocrine neoplasia type 2A.Semantic proximity Read ↗

An Analysis of Primary Hyperparathyroidism in Individuals Diagnosed with Multiple Endocrine Neoplasia Type 2Semantic proximity Read ↗

Does Genotype-Specific Phenotype in Patients with Multiple Endocrine Neoplasia Type 2 Occur as Current Guidelines Predict?Semantic proximity Read ↗

Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A in Denmark 1930–2021: A Nationwide Population-Based Retrospective StudySemantic proximity Read ↗

Advances in risk-oriented surgery for multiple endocrine neoplasia type 2Semantic proximity Read ↗

Mutation Spectrum and Associated Risks of Medullary Thyroid Cancer and All-Cause Mortality in Incidentally Identified MEN2A-Causing<i>RET</i>VariantsSemantic proximity Read ↗

Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter studySemantic proximity Read ↗

Population Prevalence of the Major Thyroid Cancer-Associated Syndromes.Semantic proximity Read ↗

Update on Multiple Endocrine Neoplasia Type 2: Focus on Medullary Thyroid CarcinomaSemantic proximity Read ↗

Multiple Endocrine Neoplasia Type 2 (MEN2) and RET Specific Modifications of the ACMG/AMP Variant Classification Guidelines and Impact on the MEN2 RET DatabaseSemantic proximity Read ↗

Genotype/phenotype correlations in multiple endocrine neoplasia type 2.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.